Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model

被引:105
|
作者
Ludewig, B [1 ]
Freigang, S
Jäggi, M
Kurrer, MO
Pei, YC
Vlk, L
Odermatt, B
Zinkernagel, RM
Hengartner, H
机构
[1] Univ Zurich, Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Univ Zurich Hosp, Inst Clin Pathol, Dept Pathol, CH-8091 Zurich, Switzerland
[3] Univ Zurich, Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland
关键词
D O I
10.1073/pnas.220427097
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Arterial inflammatory responses are thought to be a significant component of atherosclerotic disease. We describe here, using a transgenic approach, the mutual perpetuation of immune-mediated arterial inflammation and cholesterol-induced atherosclerosis. Mice expressing the bacterial transgene beta -galactosidase exclusively in cardiomyocytes and in smooth muscle cells in lung arteries and the aorta (SM-LacZ), and hypercholesterolemic apolipoprotein E-deficient SM-LacZ mice (SM-LacZ/apoE(-/-)) developed myocarditis and arteritis after immunization with dendritic cells presenting a beta -galactosidase-derived immunogenic peptide. Hypercholesterolemia amplified acute arteritis and perpetuated chronic arterial inflammation in SM-LacZ/apoE(-/-) mice, but had no major impact on acute myocarditis or the subsequent development of dilated cardiomyopathy. Conversely, arteritis significantly accelerated cholesterol-induced atherosclerosis. Taken together, these data demonstrate that the linkage of immune-mediated arteritis and hypercholesterolemia favors initiation and maintenance of atherosclerotic lesion formation. Therapeutic strategies to prevent or disrupt such self-perpetuating vicious circles may be crucial for the successful treatment of atherosclerosis.
引用
收藏
页码:12752 / 12757
页数:6
相关论文
共 50 条
  • [1] A TRANSGENIC MODEL FOR IMMUNE-MEDIATED DEMYELINATION
    HORWITZ, MS
    EVANS, CF
    LAZZARINI, RA
    OLDSTONE, MBA
    FASEB JOURNAL, 1994, 8 (04): : A198 - A198
  • [2] CHOLESTEROL-INDUCED ATHEROSCLEROSIS - CLONAL CHARACTERISTICS OF ARTERIAL LESIONS IN THE HYBRID HARE
    PEARSON, TA
    DILLMAN, J
    MALMROS, H
    STERNBY, N
    HEPTINSTALL, RH
    ARTERIOSCLEROSIS, 1983, 3 (06): : 574 - 580
  • [3] Analysis of intrahepatic lymphocyte subsets in a transgenic mouse model of immune-mediated hepatocarcinogenesis
    Nakamoto, Y
    Kaneko, S
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2006, 25 (01) : 55 - 57
  • [4] Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis
    Warren, Alessandra
    Bertolino, Patrick
    Benseler, Volker
    Fraser, Robin
    McCaughan, Geoffrey W.
    Le Couteur, David G.
    JOURNAL OF HEPATOLOGY, 2007, 46 (02) : 239 - 246
  • [5] Mouse model of immune-mediated cerebellar diseases
    Golumbek, PT
    Cross, DA
    Keeling, R
    Streif, E
    Connolly, AM
    ANNALS OF NEUROLOGY, 2003, 54 : S117 - S117
  • [6] Evaluation of L-carnitine in an animal model of cholesterol-induced atherosclerosis
    Bahrami-Bukani, Mehran
    Zarei, Leila
    Abbasi, Ata
    Farhad, Negin
    Rostami, Hawdam
    Mehrshad, Ali
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (08) : 1661 - 1666
  • [7] IRG1-Itaconate Axis Protects From Cholesterol-Induced Inflammation And Atherosclerosis
    Bozal, Fazli K.
    Cyr, Yannick
    Duran, Jose Gabriel Barcia
    Newman, Alexandra A. C.
    Amadori, Letizia
    Smyrnis, Panagiotis
    Gourvest, Morgane
    Das, Dayasagar
    Gildea, Michael
    Kaur, Ravneet
    Zhang, Tracy
    Wang, Kristin M.
    Von Itter, Richard
    Schmidt, Ann Marie
    Fisher, Edward A.
    van Solingen, Coen
    Giannarelli, Chiara
    Moore, Kathryn J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44
  • [8] Chemokines in a novel model of brain immune-mediated inflammation
    Glabinski, AR
    Bielecki, B
    Newman, T
    Perry, VH
    Ransohoff, RM
    ANNALS OF NEUROLOGY, 2004, 56 : S32 - S32
  • [9] A new mouse model of immune-mediated podocyte injury
    Meyer, T. N.
    Schwesinger, C.
    Wahlefeld, J.
    Dehde, S.
    Kerjaschki, D.
    Becker, J. U.
    Stahl, R. A. K.
    Thaiss, F.
    KIDNEY INTERNATIONAL, 2007, 72 (07) : 841 - 852
  • [10] A mouse model of immune-mediated aplastic anemia.
    Wolk, A
    Simon-Stoos, K
    Nami, I
    Concanñon, J
    Mawe, J
    Tanawattanacharoen, P
    Maung, C
    Dunn, D
    Young, NS
    Bloom, M
    BLOOD, 1998, 92 (10) : 158A - 159A